N/A N=106 Echocardiography Sub-Study of the Umbilical Cord Milking in Non-Vigorous Infants Trial (MINVI)
Birth Asphyxia
Primary: Left Ventricular Output — 225; 187 mL/kg/min — p=0.08
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=23 Feasibility of Home-based Preoperative Exercise in Older People
Colorectal Cancer
Primary: Recruitment Rate — 11; 12 Participants
N/A N=139 Safety and Effectiveness of BIOSURE RG in Cruciate Ligaments Reconstruction in Chinese
Cruciate Ligament Reconstruction · Knee
Primary: Lysholm Knee Scoring Scale 12 Months After Operation — 92.49; 94.14 score on a scale
Phase 3 N=120 A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)
Cytomegalovirus Infection
Primary: Percentage of Participants With Clinically Significant Cytomegalovirus (CMV) Infection up to Week 24 Post-Transplant — 32 Percentage of Participants
N/A N=65 Success of Dailies Total1 for Astigmatism Contact Lenses in Patients That Have Previously Failed With Toric Contact Lenses
Astigmatism
Primary: Percentage of Patients With Positive Ratings (>50 Out of 100) for Satisfaction of Comfort and Vision. — 57 Participants
Phase 2 N=84 Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors
Advanced Solid Tumors
Primary: Part 1: Number of Participants With Dose Limiting Toxicities (DLTs) — 0 Participants
Phase 4 N=45 BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging
Asthma
Primary: Change From Baseline in Untrimmed Total Mucus Volume at TLC — -0.1279; -0.1822; -0.0056; -0.1619 Milliliters (mL) — p=0.0327
N/A N=93 Testing Brief Personalized Feedback Integrating Lab-based Alcohol Cue Information
Alcohol Consumption
Primary: Daily Drinking Questionnaire — 10.24; 12.27; 8.79; 9.73 Drinks per week — p=0.83
Phase 2 N=43 Prevention of Postpartum Hemorrhage With Tranexamic Acid
Postpartum Hemorrhage
Primary: PK Model Parameter Estimates — 8.85; 10.39; 9.45 L/hr
N/A N=106 A Novel Device for the Management of ADHD
ADHD
Primary: Adult ADHD Self-Report Scale (ASRS) - Total Score at Baseline and 2 Months Follow up — 39.76; 38.27 score on a scale
N/A N=20 Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients.
Adult Cochlear Implant Recipients
Primary: Speech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0Nrearhalf) — -10.34; -6.04; -4.30 dB SRT
Phase 1 N=15 A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
Erosive Esophagitis · Heartburn · Symptomatic Nonerosive Gasroesophageal Reflux Disease
Primary: Area Under Drug Concentration-time Curve From Time 0 to 24 Hours (AUC0-24) Following the Morning Dose of Vonoprazan in Breast Milk — 179; 317 ng•h/mL
Phase 2 N=25 LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
Glioblastoma · Recurrent Glioblastoma · Supratentorial Glioblastoma
Primary: Objective Response Rate (ORR) — 0 participants
Phase 3 N=480 Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Major Depressive Disorder
Primary: Montgomery-Asberg Depression Rating Scale — -14.7; -10.2 units on a scale — p=<0.0001
Phase 3 N=92 Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin
Recurrent Clostridium Difficile Infection · Primary Clostridium Difficile Infection
Primary: Global Absence of Diarrhea Due to Clostridiodes Difficile 8 Weeks After the Start of the Treatment — 4; 9 Participants — p=0.228